180
Views
22
CrossRef citations to date
0
Altmetric
Review

Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker

, , &
Pages 425-438 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paulina Kiluk, Anna Baran, Magdalena Świderska, Magdalena Maciaszek & Iwona Flisiak. (2020) Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis. Journal of Dermatological Treatment 31:5, pages 524-530.
Read now

Articles from other publishers (21)

Mansi, Vikas Garg & Bidya Dhar Sahu. (2023) Carvacrol and its effect on cardiovascular diseases: From molecular mechanism to pharmacological modulation. Food Bioscience, pages 103444.
Crossref
Olga Dubenko, Tetyana Litovchenko, Victoria Anysienkova, Maryna Nessonova & Liudmyla Kovalenko. (2021) The prognostic value of the serum inflammatory biomarkers in patients with carotid atherosclerosis. EUREKA: Health Sciences:4, pages 26-33.
Crossref
Chris deFilippi, Mabel Toribio, Lai Ping Wong, Ruslan Sadreyev, Ida Grundberg, Kathleen V Fitch, Markella V Zanni, Janet Lo, Craig A Sponseller, Emmett Sprecher, Narges Rashidi, Melanie A Thompson, Diana Cagliero, Judith A Aberg, Laurie R Braun, Takara L Stanley, Hang Lee & Steven K Grinspoon. (2020) Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. The Journal of Infectious Diseases 222:6, pages 929-939.
Crossref
Qingqing Zhang, Yucheng Wu, Yu Lu & Xiaoqiang Fei. (2020) Role of vitamin D in risk factors of patients with type 2 diabetes mellitus. Medicina Clínica 154:5, pages 151-156.
Crossref
Qingqing Zhang, Yucheng Wu, Yu Lu & Xiaoqiang Fei. (2020) Role of vitamin D in risk factors of patients with type 2 diabetes mellitus. Medicina Clínica (English Edition) 154:5, pages 151-156.
Crossref
Laura Jackisch, Warunee Kumsaiyai, Jonathan D. Moore, Nasser Al-Daghri, Ioannis Kyrou, Thomas M. Barber, Harpal Randeva, Sudhesh Kumar, Gyanendra Tripathi & Philip G. McTernan. (2018) Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids. Diabetologia 61:5, pages 1155-1166.
Crossref
Michael H. Davidson & Lane B. Benes. (2016) The future of n-3 polyunsaturated fatty acid therapy. Current Opinion in Lipidology 27:6, pages 570-578.
Crossref
Xiangqi Wu, Yingqiang Zhang, Zhiming Wu, Wei You, Fengshuo Liang, Fei Ye & Shaoliang Chen. (2016) Plasma Lipoprotein-Associated Phospholipase A2 Level Is an Independent Predictor of High Thrombus Burden in Patients With Acute ST-segment Elevation Myocardial Infarction. International Heart Journal 57:6, pages 689-696.
Crossref
Richard L. Dunbar, Stephen J. Nicholls, Kevin C. Maki, Eli M. Roth, David G. Orloff, Danielle Curcio, Judith Johnson, Douglas Kling & Michael H. Davidson. (2015) Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Lipids in Health and Disease 14:1.
Crossref
Ann C. Skulas-Ray, Petar Alaupovic, Penny M. Kris-Etherton & Sheila G. West. (2015) Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. Journal of Clinical Lipidology 9:3, pages 360-367.
Crossref
J. FRANEKOVÁ, J. KETTNER, Z. KUBÍČEK & A. JABOR. (2015) The Importance of Age and Statin Therapy in the Interpretation of Lp-PLA2 in ACS Patients, and Relation to CRP. Physiological Research, pages 229-245.
Crossref
Mónica Acevedo, Paola Varleta, Verónica Kramer, Giovanna Valentino, Teresa Quiroga, Carolina Prieto, Jacqueline Parada, Marcela Adasme, Luisa Briones & Carlos Navarrete. (2015) Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor. International Journal of Endocrinology 2015, pages 1-7.
Crossref
Lynn Cofer-Chase. (2014) Implementing New Guidelines: Changing Paradigms for the Prevention of Cardiovascular Events. The Journal for Nurse Practitioners 10:5, pages 293-301.
Crossref
Mathieu C. Morissette, Maxime Lamontagne, Jean-Christophe Bérubé, Gordon Gaschler, Andrew Williams, Carole Yauk, Christian Couture, Michel Laviolette, James C. Hogg, Wim Timens, Sabina Halappanavar, Martin R. Stampfli & Yohan Bossé. (2014) Impact of Cigarette Smoke on the Human and Mouse Lungs: A Gene-Expression Comparison Study. PLoS ONE 9:3, pages e92498.
Crossref
John J.P. Kastelein, Kevin C. Maki, Andrey Susekov, Marat Ezhov, Borge G. Nordestgaard, Ben N. Machielse, Douglas Kling & Michael H. Davidson. (2014) Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. Journal of Clinical Lipidology 8:1, pages 94-106.
Crossref
Harold E. Bays, Christie M. Ballantyne, Rene A. Braeckman, William G. Stirtan & Paresh N. Soni. (2013) Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies. American Journal of Cardiovascular Drugs 13:1, pages 37-46.
Crossref
Rupert A. Payne. (2012) Cardiovascular risk. British Journal of Clinical Pharmacology 74:3, pages 396-410.
Crossref
Zu-Yin Chen, Chia-Hung Chiang, Chin-Chou Huang, Chia-Min Chung, Wan-Leong Chan, Po-Hsun Huang, Shing-Jong Lin, Jaw-Wen Chen & Hsin-Bang Leu. (2012) The Association of Tooth Scaling and Decreased Cardiovascular Disease: A Nationwide Population-based Study. The American Journal of Medicine 125:6, pages 568-575.
Crossref
Faiez Zannad, Guy De Backer, Ian Graham, Matthias Lorenz, Giuseppe Mancia, David A. Morrow, Željko Reiner, Wolfgang Koenig, Jean Dallongeville, Robert J. Macfadyen, Luis M. Ruilope & Lars Wilhelmsen. (2012) Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques. Fundamental & Clinical Pharmacology 26:2, pages 163-174.
Crossref
Hui-ping Gong, Yi-meng Du, Li-na Zhong, Zhao-qiang Dong, Xin Wang, Yong-jun Mao & Qing-hua Lu. (2011) Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis. Lipids in Health and Disease 10:1.
Crossref
Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W.Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki & Mary R. Dicklin. (2011) Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists. Journal of Clinical Lipidology 5:5, pages 338-367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.